Article ; Online: Current therapeutic targets and multifaceted physiological impacts of caffeine.
2023 Volume 37, Issue 12, Page(s) 5558–5598
Abstract: Caffeine, which shares consubstantial structural similarity with purine adenosine, has been demonstrated as a nonselective adenosine receptor antagonist for eliciting most of the biological functions at physiologically relevant dosages. Accumulating ... ...
Abstract | Caffeine, which shares consubstantial structural similarity with purine adenosine, has been demonstrated as a nonselective adenosine receptor antagonist for eliciting most of the biological functions at physiologically relevant dosages. Accumulating evidence supports caffeine's beneficial effects against different disorders, such as total cardiovascular diseases and type 2 diabetes. Conversely, paradoxical effects are also linked to caffeine ingestion in humans including hypertension-hypotension and tachycardia-bradycardia. These observations suggest the association of caffeine action with its ingested concentration and/or concurrent interaction with preferential molecular targets to direct explicit events in the human body. Thus, a coherent analysis of the functional targets of caffeine, relevant to normal physiology, and disease pathophysiology, is required to understand the pharmacology of caffeine. This review provides a broad overview of the experimentally validated targets of caffeine, particularly those of therapeutic interest, and the impacts of caffeine on organ-specific physiology and pathophysiology. Overall, the available empirical and epidemiological evidence supports the dose-dependent functional activities of caffeine and advocates for further studies to get insights into the caffeine-induced changes under specific conditions, such as asthma, DNA repair, and cancer, in view of its therapeutic applications. |
---|---|
MeSH term(s) | Humans ; Caffeine/pharmacology ; Caffeine/chemistry ; Diabetes Mellitus, Type 2 ; Hypertension/drug therapy ; Cardiovascular Diseases |
Chemical Substances | Caffeine (3G6A5W338E) |
Language | English |
Publishing date | 2023-09-07 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 639136-9 |
ISSN | 1099-1573 ; 0951-418X |
ISSN (online) | 1099-1573 |
ISSN | 0951-418X |
DOI | 10.1002/ptr.8000 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 3092: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.